Cargando…

Blood prognostic predictors of treatment response for patients with papillary thyroid cancer

Background: Papillary thyroid cancer (PTC) is a very common malignant disease with high morbidity. We needed some pretreatment indicators to help us predict prognosis and guide treatment. We conducted a study about some pretreatment prognostic indicators. Methods: This clinical study recruited 705 p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xiangxiang, Huang, Zhongke, He, Xianghui, Zheng, Xiangqian, Jia, Qiang, Tan, Jian, Fan, Yaguang, Lou, Cen, Meng, Zhaowei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2020
Materias:	Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578621/ https://www.ncbi.nlm.nih.gov/pubmed/33015713 http://dx.doi.org/10.1042/BSR20202544

Ejemplares similares

Changes of serum midkine as a dynamic prognostic factor to monitor disease status in papillary thyroid cancer
por: Li, Ning, et al.
Publicado: (2018)

Knockdown of LINC02471 Inhibits Papillary Thyroid Carcinoma Cell Invasion and Metastasis by Targeting miR-375
por: Chen, Dongfang, et al.
Publicado: (2020)

Identification of key genes of papillary thyroid carcinoma by integrated bioinformatics analysis
por: Xue, Gang, et al.
Publicado: (2020)

Giant Cell Tumor of Lumbar Vertebrae on MR and 18F- FDG PET/CT: A Case Report and Literature Review
por: Liu, Xiangxiang, et al.
Publicado: (2023)

OGDHL closely associates with tumor microenvironment and can serve as a prognostic biomarker for papillary thyroid cancer
por: Mao, Min, et al.
Publicado: (2021)

Experimental study on changes in metabolic mechanism of papillary thyroid carcinoma complicated with Hashimoto’s thyroiditis
por: Sun, Danyang, et al.
Publicado: (2023)

BRAF mutation is not predictive of long-term outcome in papillary thyroid carcinoma
por: Henke, Lauren E, et al.
Publicado: (2015)

Multicentric occurrence of multiple papillary thyroid carcinomas –HUMARA and BRAF mutation analysis
por: Nakazawa, Tadao, et al.
Publicado: (2015)

Clinicopathological Features as Prognostic Predictors of Poor Outcome in Papillary Thyroid Carcinoma
por: Póvoa, Antónia Afonso, et al.
Publicado: (2020)

MiR-192-5p inhibits proliferation, migration, and invasion in papillary thyroid carcinoma cells by regulation of SH3RF3
por: Fu, Songbo, et al.
Publicado: (2021)

Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors
por: Zhang, Peitao, et al.
Publicado: (2022)

LncRNA AWPPH as a prognostic predictor in human cancers in Chinese population: evidence from meta-analysis
por: Li, Yongfeng, et al.
Publicado: (2021)

Impact of Extranodal Extension on Risk Stratification in Papillary Thyroid Carcinoma
por: Kim, Hye In, et al.
Publicado: (2019)

Kinetic Analysis of Growth Activity in Enlarging Papillary Thyroid Microcarcinomas
por: Ito, Yasuhiro, et al.
Publicado: (2019)

A molecular approach combined with American Thyroid Association classification better stratifies recurrence risk of classic histology papillary thyroid cancer
por: Lin, Alexander J., et al.
Publicado: (2018)

Nuclear Factor-Kappa B Inhibition Can Enhance Apoptosis of Differentiated Thyroid Cancer Cells Induced by (131)I
por: Meng, Zhaowei, et al.
Publicado: (2012)

Author Correction: Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors
por: Zhang, Peitao, et al.
Publicado: (2022)

Effect of chronic lymphocytic thyroiditis on the efficacy and safety of ultrasound‐guided radiofrequency ablation for papillary thyroid microcarcinoma
por: Zhang, Yan, et al.
Publicado: (2019)

Patients' View on the Management of Papillary Thyroid Microcarcinoma: Active Surveillance or Surgery
por: Yoshida, Yusaku, et al.
Publicado: (2020)

Whole-Exome Sequencing of Matched Primary and Metastatic Papillary Thyroid Cancer
por: Masoodi, Tariq, et al.
Publicado: (2020)

Progression of Low-Risk Papillary Thyroid Microcarcinoma During Active Surveillance: Interim Analysis of a Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma in Korea
por: Lee, Eun Kyung, et al.
Publicado: (2022)

AST/ALT ratio as a significant predictor of the incidence risk of prostate cancer
por: Zhou, Jiatong, et al.
Publicado: (2020)

Which is preferred for initial treatment of papillary thyroid cancer, total thyroidectomy or lobotomy?
por: Wu, Zhen, et al.
Publicado: (2021)

LINC00311 promotes cancer stem‐like properties by targeting miR‐330‐5p/TLR4 pathway in human papillary thyroid cancer
por: Gao, Yu, et al.
Publicado: (2020)

Analysis of predictability of F‐18 fluorodeoxyglucose‐PET/CT in the recurrence of papillary thyroid carcinoma
por: Kim, Suk Kyeong, et al.
Publicado: (2016)

A methylomics‐associated nomogram predicts recurrence‐free survival of thyroid papillary carcinoma
por: Chen, Hengyu, et al.
Publicado: (2020)

Population‐based study evaluating and predicting the probability of death resulting from thyroid cancer among patients with papillary thyroid microcarcinoma
por: Wang, Kun, et al.
Publicado: (2019)

Risk factors for level V lymph node metastases in solitary papillary thyroid carcinoma with clinically lateral lymph node metastases
por: Yang, Jing, et al.
Publicado: (2016)

Relationship Between Thyroid Autoantibodies and Recurrence of Papillary Thyroid Carcinoma in Children and Adolescents
por: Huang, Dongmei, et al.
Publicado: (2022)

In silico DNA methylation analysis identifies potential prognostic biomarkers in type 2 papillary renal cell carcinoma
por: Yang, Man, et al.
Publicado: (2019)

Changes in Treg numbers and activity in papillary thyroid carcinoma with and without Hashimoto’s thyroiditis
por: Zhao, Na, et al.
Publicado: (2020)

Comprehensive Analysis of Prognostic Alternative Splicing Signature Reveals Recurrence Predictor for Papillary Thyroid Cancer
por: Liu, Mian, et al.
Publicado: (2021)

Active surveillance as a management strategy for papillary thyroid microcarcinoma
por: Zhang, Huan, et al.
Publicado: (2020)

Effects of Pregnancy on Papillary Microcarcinomas of the Thyroid Re-Evaluated in the Entire Patient Series at Kuma Hospital
por: Ito, Yasuhiro, et al.
Publicado: (2016)

Scintigraphic Detection of Dual Ectopic Thyroid Tissue: Experience of a Chinese Tertiary Hospital
por: Meng, Zhaowei, et al.
Publicado: (2014)

Prognostic parameters for recurrence of papillary thyroid microcarcinoma
por: Kim, Tae Yong, et al.
Publicado: (2008)

(99m)TcO(4)(-)/(99m)Tc-MIBI dual-tracer scintigraphy for preoperative localization of parathyroid adenomas
por: Huang, Zhongke, et al.
Publicado: (2018)

Molecular Predictors for Advanced Papillary Thyroid Carcinoma Recurrence
por: de Castro, Taciana Padilha, et al.
Publicado: (2019)

Long noncoding RNA CASC9 promotes the proliferation and metastasis of papillary thyroid cancer via sponging miR‐488‐3p
por: Chen, Yonghui, et al.
Publicado: (2020)

Ultrasound-guided core needle biopsy for differential diagnosis of thyroid nodules: A systematic review and meta-analysis
por: Liu, Na, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_f94v0ueod9r9abbjmt2ocp00r1